KARSEN PERRY A
Insider CIK 1260573 · OMED Director · AGIO Director · VYGR Director · JNCE Director · NTLA Director · GRPH Director · NAVB Director · CELG see remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GRPH Graphite Bio, Inc. | A Award deriv | 2023-07-19 | 2023-07-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 75,880 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 16,260 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 13,350 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 20,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | U Tender | 2023-05-03 | 2023-05-04 | 5,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-06-24 | 2022-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GRPH Graphite Bio, Inc. | A Award deriv | 2022-06-21 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 19,763 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 8,126 | — | $0 | 164,034 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-06-18 | 2021-06-22 | 15,700 | — | $0 | 15,700 | SEC↗ |
| GRPH Graphite Bio, Inc. | A Award deriv | 2021-03-17 | 2021-07-01 | 18,698 | — | $0 | 18,698 | SEC↗ |
| GRPH Graphite Bio, Inc. | A Award deriv | 2021-03-11 | 2021-07-01 | 19,763 | $5.06 | $100.0K | 19,763 | SEC↗ |
| GRPH Graphite Bio, Inc. | A Award deriv | 2021-01-13 | 2021-07-01 | 74,794 | — | $0 | 74,794 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-12-17 | 2020-12-18 | 19,000 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-12-17 | 2020-12-18 | 19,000 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-12-17 | 2020-12-18 | 19,000 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-12-17 | 2020-12-18 | 31,764 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-12-17 | 2020-12-18 | 21,336 | $54.33 | $1.16M | 5,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-12-17 | 2020-12-18 | 45,450 | $53.69 | $2.44M | 26,336 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-12-17 | 2020-12-18 | 19,000 | $14.35 | $272.6K | 55,764 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-12-17 | 2020-12-18 | 19,000 | $15.78 | $299.8K | 93,764 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-12-17 | 2020-12-18 | 19,000 | $25.98 | $493.6K | 74,764 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-12-17 | 2020-12-18 | 31,764 | $18.00 | $571.8K | 36,764 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-12-17 | 2020-12-18 | 21,978 | $52.52 | $1.15M | 71,786 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-07-02 | 15,700 | — | $0 | 15,700 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-06-29 | 13,550 | — | $0 | 13,550 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-06-18 | 2020-06-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2019-06-13 | 2019-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-13 | 15,700 | — | $0 | 15,700 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2019-05-21 | 2019-05-22 | 19,000 | — | $0 | 19,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | U Tender | 2019-04-23 | 2019-04-23 | 80,500 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 13,550 | — | $0 | 13,550 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2018-06-14 | 2018-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2018-05-17 | 2018-05-21 | 19,000 | — | $0 | 19,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-02-26 | 2018-02-28 | 120,000 | — | $0 | 120,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2018-02-26 | 2018-02-28 | 70,500 | — | $0 | 80,500 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2017-06-29 | 2017-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2017-06-05 | 2017-06-07 | 10,000 | $3.46 | $34.6K | 10,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2017-06-01 | 2017-06-05 | 5,000 | $11.99 | $60.0K | 5,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2017-05-18 | 2017-05-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | P Buy | 2017-02-01 | 2017-02-02 | 5,000 | $16.00 | $80.0K | 5,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2016-06-15 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2016-05-05 | 2016-05-09 | 31,764 | — | $0 | 31,764 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2016-01-04 | 2016-01-06 | 30,189 | — | $0 | 30,189 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-12-17 | 2015-12-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2015-12-17 | 2015-12-18 | 3,888 | $112.17 | $436.1K | 66,432 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-12-17 | 2015-12-18 | 7,500 | — | $0 | 70,320 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2015-07-27 | 2015-07-29 | 12,125 | — | $0 | 12,125 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | D To issuer | 2015-07-16 | 2015-07-21 | 22,000 | $0.01 | $220 | 37,528 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2015-06-23 | 2015-06-25 | 10,625 | — | $0 | 23,125 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-05-13 | 2015-05-15 | 6,160 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-05-13 | 2015-05-15 | 4,162 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-05-13 | 2015-05-15 | 8,324 | — | $0 | 4,162 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-05-13 | 2015-05-15 | 11,824 | — | $0 | 5,912 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-05-13 | 2015-05-15 | 4,162 | $36.47 | $151.8K | 109,993 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-05-13 | 2015-05-15 | 6,160 | $36.90 | $227.3K | 85,683 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-05-13 | 2015-05-15 | 11,824 | $59.24 | $700.5K | 97,507 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-05-13 | 2015-05-15 | 8,324 | $49.48 | $411.9K | 105,831 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2015-05-04 | 2015-05-04 | 12,125 | — | $0 | 12,125 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-04-30 | 2015-05-04 | 11,200 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2015-04-30 | 2015-05-04 | 5,807 | $108.06 | $627.5K | 79,523 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-04-30 | 2015-05-04 | 11,200 | — | $0 | 85,330 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2015-03-26 | 2015-03-30 | 22,000 | — | $0 | 59,528 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-03-01 | 2015-03-03 | 8,334 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2015-03-01 | 2015-03-03 | 4,321 | $121.53 | $525.1K | 74,130 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-03-01 | 2015-03-03 | 8,334 | — | $0 | 78,451 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-02-11 | 2015-02-13 | 8,324 | — | $0 | 4,162 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-02-11 | 2015-02-13 | 11,248 | — | $0 | 5,626 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-02-11 | 2015-02-13 | 8,324 | — | $0 | 4,162 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-02-11 | 2015-02-13 | 8,324 | $36.68 | $305.3K | 86,765 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2015-02-11 | 2015-02-13 | 27,896 | $120.12 | $3.35M | 70,117 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-02-11 | 2015-02-13 | 11,248 | $40.22 | $452.4K | 98,013 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-02-11 | 2015-02-13 | 8,324 | $34.70 | $288.8K | 78,441 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2015-02-06 | 2015-02-10 | 15,758 | $118.75 | $1.87M | 70,117 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award | 2015-02-06 | 2015-02-10 | 30,404 | — | $0 | 85,875 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2015-02-05 | 2015-02-09 | 7,276 | $1.89 | $13.8K | 37,528 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2015-02-02 | 2015-02-04 | 10,175 | — | $0 | 10,175 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2014-12-30 | 2015-01-02 | 23,334 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2014-12-30 | 2015-01-02 | 19,273 | $113.37 | $2.18M | 55,471 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2014-12-30 | 2015-01-02 | 23,334 | $29.75 | $694.2K | 74,744 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2014-12-19 | 2014-12-23 | 15,670 | — | $0 | 15,670 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2014-11-12 | 2014-11-14 | 8,324 | — | $0 | 4,162 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2014-11-12 | 2014-11-14 | 12,500 | — | $0 | 6,160 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2014-11-12 | 2014-11-14 | 11,250 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2014-11-12 | 2014-11-14 | 12,500 | $36.96 | $462.0K | 82,506 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2014-11-12 | 2014-11-14 | 8,324 | $36.47 | $303.6K | 90,830 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2014-11-12 | 2014-11-14 | 39,420 | $107.23 | $4.23M | 51,410 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2014-11-12 | 2014-11-14 | 11,250 | $25.77 | $289.9K | 70,006 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2014-11-10 | 2014-11-12 | 10,252 | $1.32 | $13.5K | 30,252 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2014-10-27 | 2014-10-29 | 10,175 | — | $0 | 10,175 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2014-08-04 | 2014-08-05 | 46,450 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2014-08-04 | 2014-08-05 | 39,104 | $87.55 | $3.42M | 58,756 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2014-08-04 | 2014-08-05 | 46,450 | $28.16 | $1.31M | 97,860 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2014-07-28 | 2014-07-29 | 20,350 | — | $0 | 20,350 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2014-07-28 | 2014-07-29 | 4,200 | — | $0 | 4,200 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2014-05-30 | 2014-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2014-05-01 | 2014-05-05 | 11,667 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2014-05-01 | 2014-05-05 | 11,922 | $146.78 | $1.75M | 25,705 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2014-05-01 | 2014-05-05 | 11,667 | $59.50 | $694.2K | 37,627 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2014-03-03 | 2014-03-05 | 2,408 | $159.05 | $383.0K | 25,960 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2014-02-17 | 2014-02-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award | 2014-02-12 | 2014-02-14 | 15,188 | — | $0 | 36,242 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2014-02-12 | 2014-02-14 | 7,874 | $160.54 | $1.26M | 28,368 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2014-02-03 | 2014-02-05 | 11,825 | — | $0 | 11,825 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2013-12-27 | 2013-12-31 | 7,777 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2013-12-27 | 2013-12-31 | 4,032 | $168.93 | $681.1K | 21,054 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2013-12-27 | 2013-12-31 | 7,777 | — | $0 | 25,086 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2013-12-02 | 2013-12-04 | 2,190 | — | $0 | 2,190 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2013-12-02 | 2013-12-04 | 8,750 | — | $0 | 8,750 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2013-11-01 | 2013-11-05 | 10,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2013-11-01 | 2013-11-05 | 5,185 | $151.31 | $784.5K | 17,309 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2013-11-01 | 2013-11-05 | 10,000 | — | $0 | 22,494 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2013-10-28 | 2013-10-28 | 11,825 | — | $0 | 11,825 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2013-08-02 | 2013-08-02 | 23,333 | — | $0 | 11,667 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2013-08-02 | 2013-08-02 | 69,675 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2013-08-02 | 2013-08-02 | 25,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2013-08-02 | 2013-08-02 | 69,675 | $56.32 | $3.92M | 93,464 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2013-08-02 | 2013-08-02 | 23,333 | $59.50 | $1.39M | 23,789 | SEC↗ |
| CELG CELGENE CORP /DE/ | F Tax w/h | 2013-08-02 | 2013-08-02 | 12,962 | $147.35 | $1.91M | 105,502 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2013-08-02 | 2013-08-02 | 93,008 | $146.50 | $13.63M | 12,494 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2013-08-02 | 2013-08-02 | 25,000 | — | $0 | 118,464 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2013-07-29 | 2013-07-31 | 11,825 | — | $0 | 11,825 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2013-05-13 | 2015-05-15 | 47,173 | $115.00 | $5.42M | 62,820 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2013-04-29 | 2013-05-01 | 5,500 | — | $0 | 5,500 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2013-04-29 | 2013-05-01 | 11,825 | — | $0 | 11,825 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2013-01-28 | 2013-01-30 | 8,325 | — | $0 | 8,325 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2012-12-17 | 2012-12-19 | 11,250 | — | $0 | 11,250 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2012-12-17 | 2012-12-19 | 3,750 | — | $0 | 3,750 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2012-10-31 | 2012-11-02 | 8,325 | — | $0 | 8,325 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2012-07-30 | 2012-08-01 | 8,325 | — | $0 | 8,325 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2012-04-30 | 2012-05-01 | 8,325 | — | $0 | 8,325 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2012-04-30 | 2012-05-01 | 5,600 | — | $0 | 5,600 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2012-03-01 | 2012-03-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2012-03-01 | 2012-03-07 | 4,167 | — | $0 | 4,167 | SEC↗ |